Are muscle relaxants, such as cyclobenzaprine (Flexeril) or metaxalone (Skelaxin), recommended for treating finger sprains?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Muscle Relaxants Are Not Recommended for Finger Sprains

Muscle relaxants such as cyclobenzaprine (Flexeril) or metaxalone (Skelaxin) should not be used for finger sprains, as they are only indicated for acute, painful musculoskeletal conditions involving muscle spasm, and finger sprains do not involve true muscle spasm requiring these medications. 1, 2

Why Muscle Relaxants Are Inappropriate for Finger Sprains

FDA-Approved Indications Do Not Include Finger Injuries

  • Cyclobenzaprine is FDA-approved only as "an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions" and should be used only for short periods (up to two or three weeks). 1

  • Metaxalone is similarly indicated only "as an adjunct to rest, physical therapy and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions." 2

  • Critically, the FDA label for metaxalone explicitly states that "metaxalone does not directly relax tense skeletal muscles in man," meaning its mechanism is likely related to sedative properties rather than actual muscle relaxation. 2

  • Finger sprains involve ligamentous injury, not the type of muscle spasm these medications target (which typically refers to large muscle groups in conditions like acute low back pain). 1, 2

Evidence Shows Muscle Relaxants Are Not Effective for Musculoskeletal Pain

  • The American Geriatrics Society emphasizes that muscle relaxants should not be prescribed in the mistaken belief that they relieve muscle spasm, as their effects are nonspecific and not related to actual muscle relaxation. 3

  • Guidelines specifically state that muscle relaxants are not effective for musculoskeletal pain, and their use may lead to unnecessary medication side effects, including sedation and fall risk. 3

  • For older persons specifically, these drugs are associated with greater risk for falls. 3

Limited Evidence Base and Significant Side Effects

  • Evidence supporting muscle relaxants even for their approved indications (acute low back pain) shows only moderate effects, and most trials have involved acute rather than chronic pain. 4

  • A systematic review found that muscle relaxants like cyclobenzaprine, carisoprodol, and metaxalone have equal efficacy for their approved indications, but their side effects vary considerably, with all causing central nervous system effects including drowsiness, sedation, fatigue, and dizziness. 5, 6, 7

  • In rheumatoid arthritis patients, benzodiazepine muscle relaxants (diazepam, triazolam) and non-benzodiazepines (zopiclone) showed no benefit in improving pain over 24 hours to 2 weeks, but were associated with significant adverse events (number needed to harm = 3), predominantly drowsiness and dizziness. 8

  • There is concern that some of these medications can lead to abuse and addiction, particularly carisoprodol. 4, 5, 6

Common Pitfalls to Avoid

  • Do not prescribe muscle relaxants simply because a patient reports "muscle pain" or "stiffness" around a finger sprain—this does not represent true muscle spasm requiring these medications. 3, 1, 2

  • Avoid the misconception that these drugs directly relax muscles—their mechanism is primarily sedative, not muscle-specific. 2

  • Remember that finger sprains are ligamentous injuries requiring rest, ice, compression, elevation, and possibly NSAIDs for pain/inflammation—not muscle relaxants. 9

References

Guideline

Management of Costochondritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A review of three commonly prescribed skeletal muscle relaxants.

Journal of back and musculoskeletal rehabilitation, 2000

Research

Muscle relaxants for pain management in rheumatoid arthritis.

The Cochrane database of systematic reviews, 2012

Research

Non-steroidal anti-inflammatory drugs (NSAIDs) for trigger finger.

The Cochrane database of systematic reviews, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.